Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

A shared care approach to the management of erectile dysfunction in the community

Abstract

Erectile dysfunction (ED) affects men of all ages and results in considerable distress and impact on quality of life for those who suffer from it. As ED is associated with a wide variety of under-lying conditions and cardiovascular co-morbidities, there is a requirement for diversity of treatment options and several factors must be considered to customise and optimise therapy. In the ideal holistic approach to management of the ED patient, both primary care and specialist physicians have an important role to play. This article reports on a sequential approach for the diagnosis and treatment of ED, with an emphasis on ‘shared care’. The deliberations are based on a pan-European inter-disciplinary group that met at the Lygon Arms, UK on 22 February 2002.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. NIH Consensus Conference on Impotence JAMA 1993 270: 83–90

  2. Krane RJ, Goldstein I, Saenz de Tejada I . Impotence New Engl J Med 1989 321: 1648–1659

    Article  CAS  Google Scholar 

  3. Lue T . Impotence: a patient's goal-directed approach to treatment World J Urol 1990 8: 67–74

    Article  Google Scholar 

  4. Hatzichristou DG, Bertero ED, Goldstein I . Decision making in the evaluation of impotence: the patient profile-oriented algorithm Sex Disabil 1994 12: 29–37

    Article  Google Scholar 

  5. Korenman SG . Advances in the understanding and management of erectile dysfunction J Clin Endocrinol Metab 1995 80: 1985–1988

    CAS  PubMed  Google Scholar 

  6. Feldman HA et al. Impotence and its medical and psychological correlates: results of the Massachusetts Male Ageing Study J Urol 1994 151: 54–61

    Article  CAS  Google Scholar 

  7. Osterloh I, Eardley I, Carson C, Padma-Nathan H . Sildenafil: a selective phosphodiesterase PDE 5 inhibitor in the treatment of ED In: Carson C, Kirby R, Goldstein I (eds) Textbook of Erectile Dysfunction Isis Medical Media: Oxford 1999 pp 285–308

    Google Scholar 

  8. Heaton JPW . Characterising the benefit of apomorphine as an optimised treatment for representative populations with erectile dysfunction Int J Impot Res 2001 13: (Suppl 3) S35–S39

    Article  Google Scholar 

  9. Dula E, Bukofzer S, Pedock R, George M . Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction Eur Urol 2001 39: 558–564

    Article  CAS  Google Scholar 

  10. Jardin A, Wagner G, Khoury S, Guiliano F, Goldstein I, Padma-Nathan H, Rosen R . Recommendations of the First International Consultation on Erectile Dysfunction In: Jardin A et al (eds) Erectile Dysfunction Plymbridge Distributors Ltd: Plymouth, UK 2000 pp 711–726

    Google Scholar 

  11. Wyllie MG, Andersson K-E . Orally active agents: the potential of alpha-adrenoceptor antagonists In: Carson C, Kirby R, Goldstein I (eds) Textbook of Erectile Dysfunction Isis Medical Media: Oxford 1999 pp 317–322

    Google Scholar 

  12. Sachs BD . The artificial organic-psychogenic distinction and other problems in the classification of erectile dysfunction Int J Impot Res 2001 13: (Suppl 1) S31

    Google Scholar 

  13. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Ageing Study J Urol 1994 151: 54–61

    Article  CAS  Google Scholar 

  14. Heaton JPW, Dean J, Sleep DJ . Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction Int J Impot Res 2002 14: 61–64

    Article  CAS  Google Scholar 

  15. McCulloch AR, Siegel RL, Shpilsky AB . Intercourse success rates with sildenafil citrate J Urol 2001 165: 699A

    Google Scholar 

  16. Kirby R, Fitzpatrick J, Kirby M, Fitzpatrick A . Shared Care for Prostatic Diseases Isis Medical Media: Oxford, UK 1994

    Google Scholar 

  17. Lewis R, Hatzichristou D, Laumann E, McKinley J . Epidemiology and natural history of erectile dysfunction; risk factors including iatrogenic and ageing In: Jardin A et al (eds) Erectile Dysfunction Plymbridge Distributors Ltd: Plymouth, UK 2000 pp 19–51

    Google Scholar 

  18. Hanson-Divers C, Lue TF, Crawford SY, Rosen RC . Health outcomes variables important to patients in the treatment of erectile dysfunction J Urol 1998 159: 1541–1547

    Article  CAS  Google Scholar 

  19. Bukofzer S, Livesey N . Safety and tolerability of apomophine SL (Uprima) Int J Impot Res 2001 13: (Suppl 3) S40–S44

    Article  Google Scholar 

  20. Adams MA, Perdock R, Padley RJ, Sleep DJ . Safety and tolerability of apomorphine SL in men with cardiovascular disease Eur Urol 2002 in press

  21. Cohen JS . Comparison of FDA reports of patient deaths associated with sildenafil and with injectable alprostadil Ann Pharmacother 2001 35: 285–288

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wagner, G., The Lygon Arms Group:., Claes, H. et al. A shared care approach to the management of erectile dysfunction in the community. Int J Impot Res 14, 189–194 (2002). https://doi.org/10.1038/sj.ijir.3900882

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3900882

Keywords

This article is cited by

Search

Quick links